Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » ....Support for Diabetic research/Testing..

 - UBBFriend: Email this page to someone!    
Author Topic: ....Support for Diabetic research/Testing..
jackbequick
Member


Rate Member
Icon 14 posted      Profile for jackbequick     Send New Private Message       Edit/Delete Post   Reply With Quote 
[Smile] ..ProtoKinetix Funds Independent Confirmatory Trials..Hopefully, will get the ball rolling in this court
to help put an end to this "Killer"...
....Diabetes is divided into 3 types: type 1 diabetes (previously referred to as
“juvenile” diabetes), type 2 diabetes (previously referred to as “adult-onset”
diabetes), and gestational diabetes (a form of diabetes that occurs only during
pregnancy).
..In the past, type 1 diabetes typically affected young people who had few
symptoms or signs of the disease before experiencing an abrupt onset, type 2
diabetes primarily affected adults, and gestational diabetes affected pregnant
women and indicated a higher-than-average risk for type 2 diabetes. While the
epidemiological profiles of type 1 diabetes and gestational diabetes have remained
constant, the profile of type 2 diabetes has changed dramatically in recent years.
..Type 2 diabetes used to be an adult-onset disorder; now type 2 diabetes affects
children, adolescents, and young adults as well.
Since the onset of type 1 diabetes is usually relatively sudden and associated with
symptoms that require care, screening for type 1 diabetes has not been considered
useful.
..Type 2 diabetes, on the other hand, has a longer asymptomatic phase. Early
recognition and intervention can forestall its onset and may even prevent its
emergence. For reasons not completely understood, but seemingly related (at
least in part) to obesity, changing dietary habits, and levels of physical activity,
the incidence of type 2 diabetes is increasing. It is also being identified at
younger and younger ages.
..Type 2 diabetes (hereafter referred to as diabetes) affects over 21 million Americans
(7% of the United States population) and more than 6 million Americans with
diabetes are undiagnosed. In addition, 41 million adults age 40 to 74 have
prediabetes, a condition that increases the risk of diabetes, heart disease, and
stroke.1-2 People with prediabetes have a high blood sugar level but not high
enough to be classified as diabetes. Many people with prediabetes will develop
clinical diabetes. Alarmingly, the prevalence of type 2 diabetes (including
gestational diabetes) in the United States has increased 61% since 1990.3
..Diabetes is a major cause of premature morbidity and disability, and
uncontrolled diabetes can cause death. Diabetes is the sixth leading cause of
death in the United States — each year 200,000 Americans die of complications
resulting from the disease.1
..Death rates are about 2 to 4 times higher for adults with diabetes than for those
without the disease.2 Heart disease and stroke are leading causes of diabetesrelated
deaths. Uncontrolled diabetes can also cause blindness, neurologic
problems, kidney failure, pregnancy complications, and amputations of toes, feet,
or legs. Persons with diabetes are at higher risk of acquiring influenza and
pneumonia, which are additional causes of disproportionate death among
diabetics. Each year, 12,000 to 24,000 people become blind, 42,813 have kidney
failure, and 82,000 have leg, foot, or toe amputations.2

....ProtoKinetix Funds Independent Confirmatory Trials (PKTX.OB)

VANCOUVER, British Columbia--(Business Wire)--
ProtoKinetix (OTCBB: PKTX) (http://www.protokinetix.com), a biotechnology
company that has developed and patented a family of synthetic anti-aging
glycopeptides (AAGP) for medicine, biotechnology and cosmetic industries today
announced that the Company has completed the funding requirements for trials to
test the effectiveness of their AAGP molecule`s anti-inflammatory properties.

..This course of action is a follow up to the many previous results showing that
AAGP has the ability to provide a layer of protection against the inflammation
of cells. The inflammation of pancreatic islet cells is widely recognized as the
root cause of diabetes. Inflammation is, in general present in many diseases and
disorders including atherosclerosis, arthritis, and asthma.

"We expect these confirmatory trials will clearly indicate just how effective
the AAGP molecule is against a host of inflammatory conditions," said Ross L.
Senior, CEO of ProtoKinetix.

--------------------
The check is in the mail...

Posts: 196 | From: Florida | Registered: Dec 2009  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share